2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Lung Neoplasms
84
Prostatic Neoplasms
73
Leukemia, Myeloid, Acute
72
Carcinoma, Non-Small-Cell Lung
61
Neoplasm Metastasis
60
Breast Neoplasms
56
Multiple Myeloma
47
Colorectal Neoplasms
46
Pancreatic Neoplasms
42
Carcinoma, Renal Cell
36
Myelodysplastic Syndromes
35
Melanoma
34
Ovarian Neoplasms
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Triple Negative Breast Neoplasms
28
Glioblastoma
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, Large B-Cell, Diffuse
26
Urinary Bladder Neoplasms
25
Lymphoma
23
Squamous Cell Carcinoma of Head and Neck
22
Burkitt Lymphoma
22
Fallopian Tube Neoplasms
21
Glioma
20
Carcinoma, Hepatocellular
20
Brain Neoplasms
18
Mouth Neoplasms
17
Lymphoma, Non-Hodgkin
17
Leukemia, Biphenotypic, Acute
17
Endometrial Neoplasms
17
Interventions
Exercise
5
Vitamin D
3
Resistance Training
3
Omeprazole
3
Etanercept
3
Dexmedetomidine
3
Ascorbic Acid
3
salicylsalicylic acid
2
palbociclib
2
epigallocatechin gallate
2
XENP 1595
2
Tea
2
Tablets
2
Surgical Procedures, Operative
2
Sufentanil
2
Spironolactone
2
Probiotics
2
Pioglitazone
2
Oxycodone
2
Nutrition Assessment
2
Morphine
2
Metformin
2
Ketorolac
2
Infliximab
2
Ibuprofen
2
Fish Oils
2
Endurance Training
2
Colchicine
2
Blood Specimen Collection
2
Aspirin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Specimen Handling
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled